IP Library Granted Patent US 7,879,604
Granted Patent B2
US 7,879,604 · App. 11/063,183 · Granted Feb 1, 2011

Intervertebral disk repair, methods and devices therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,604
App. No.
11/063,183
Granted
Feb 1, 2011
Kind
B2
Abstract

The present application discloses compositions, methods and devices for treatment of a degenerative intervertebral disc. A composition can comprise chondrocytes expressing type II collagen. These chondrocytes can be obtained from human cadavers up to about two weeks following death, and can be grown in vitro. The compositions can further comprise one or more biocompatible molecules. Treatment of a degenerative disc can comprise injecting or implanting a composition comprising the chondrocytes into a degenerative disc.

Claims (12)

1. A method of repairing a degenerative intervertebral disc in a human subject in need of such repair, the method comprising:

(a) isolating a population of articular cartilage chondrocytes from a cadaver donor;

(b) expanding said population in vitro in a substantially serum-free growth medium, thereby yielding expanded articular cartilage chondrocytes;

(c) mixing said expanded articular cartilage chondrocytes with a thrombin solution to yield a mixture of expanded articular cartilage chondrocytes in thrombin;

(d) adding fibrin to said mixture to yield a suspension of expanded articular cartilage chondrocytes; and then immediately

(e) injecting said suspension into a degenerative intervertebral disc of a human subject.

2. The method of claim 1 , wherein expanding the population of articular cartilage chondrocytes in vitro comprises expanding the articular cartilage chondrocytes at least 10 fold in vitro prior to injecting the suspension of expanded articular cartilage chondrocytes.

3. The method of claim 1 , wherein injecting the suspension of expanded articular cartilage chondrocytes into the intervertebral disc comprises injecting the suspension of chondrocytes into the nucleus pulposus of the intervertebral disc.

4. The method of claim 1 , further comprising extracting the viable articular chondrocytes from a cadaver no older than about 20 years of age at time of death.

5. The method of claim 1 , further comprising extracting the population of articular cartilage chondrocytes from a cadaver donor deceased for at least about one hour at time of extraction.

6. The method of claim 1 , further comprising forming an aperture in the annulus of the intervertebral disc.

7. The method of claim 1 wherein after injection, at least a portion of the injected articular cartilage chondrocytes produce an extracellular cartilaginous matrix that integrates with tissue of the disc.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2016
From: MIDCAP FUNDING XVIII TRUST, AS SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL SBIC, LP
To: ISTO TECHNOLOGIES, INC.
Reel/Frame 038903/0645 →
SECURITY INTEREST Recorded Jan 23, 2015
From: ISTO TECHNOLOGIES, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 034805/0001 →